You are here

MULLERIAN INHIBITING SUBSTANCE

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 4729
Amount: $266,000.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1987
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
14 Cambridge Center
Cambridge, MA 02142
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Richard L Cate
 Principal Investigator
 (617) 864-8900
Business Contact
Phone: () -
Research Institution
N/A
Abstract

MULLERIAN INHIBITING SUBSTANCE (MIS), A PRODUCT OF THE FETALTESTIS, IA A HIGH MOLECULAR WEIGHT GLYCOPROTEIN THAT INITIATES REGRESSION OF THE MULLERIAN DUCT, THE ANLAGEN OF THE UTERUS, FALLOPIAN TUBE, AND UPPER VAGINA. BIOGEN RESEARCHERS HAVE SHOWN THAT THIS FETAL REGRESSOR CAN ALSO INHIBIT THE GROWTH OF SOME TUMORS DERIVED FROM THE CELL TYPES WHICH RESPOND TO THE FETAL REGRESSOR IN EMBRYONIC LIFE. BIOLOGICALLY ACTIVE MIS HAS BEEN PURIFIED 30,000-FOLDFROM BOVINE TESTIS. HOWEVER, THE AMOUNT OF BOVINE MIS THAT CAN BE ISOLATED BY CONVENTIONAL MEANS IS TOO LOW TO PERMIT BROAD ONCOLOGICAL STUDIES, AND THE HUMAN PROTEIN IS NOT AVAILABLE. BIOGEN PROPOSES TO USE RECOMBINANT DNA TECHNOLOGY TO ISOLATE THE GENES FOR BOVINE AND HUMAN MIS ANDTO EXPRESS THOSE GENES IN E. COLI OR ANIMAL CELLS. A PROCESS FOR PURIFYING LARGE AMOUNTS OF HUMAN MIS IN ORDER TOTEST THE EFFICACY OF MIS AS AN ANTICANCER DRUG IN A CLINICALSETTING WILL THEN BE DEVELOPED. SPECIFICALLY IN PHASE I, PEPTIDES OF BOVINE MIS AND GENERATE OLIGONUCLEOTIDE PROBES WILL BE SEQUENCED. THE PROBES WILL BE USED TO ISOLATE THE BOVINE CLONE FROM A CDNA LIBRARY, WHICH WILL THEN BE USED TOISOLATE THE HUMAN GENE.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government